Table 1 Characteristics of the study cohort
Characteristic | PSA (ng/ml) | Total | |
|---|---|---|---|
4.0–10.0 | 10.1–20.0 | ||
No. of subjects (n) | 465 | 290 | 755 |
Age (year) | 62.8 ± 9.0 | 67.9 ± 8.67 | 64.8 ± 9.26 |
DRE positive | 62 | 76 | 138 |
TPV | 48.17 ± 20.25 | 54.46 ± 27.00 | 50.59 ± 23.26 |
TZV | 29.90 ± 16.57 | 35.2 ± 23.58 | 31.95 ± 19.20 |
Biopsy positive | 96 | 111 | 206 |
Positive detection rate (%) | 20.6 | 38.2 | 27.2 |
DRE positive (n) | 62 | 76 | 138 |
Gleason score | |||
≤ 6 | 68 | 64 | 132 |
7 | 21 | 19 | 40 |
8–10 | 7 | 27 | 34 |